SUBSCRIBE: eNewsletter
- TRENDING:
- AMD
- DME
- Ophthalmic Tech's Community
- Money Matters
Diabetic Retinopathy
Aflibercept helps in ME patients with DR after cataract surgery
October 10, 2017By Lynda Charters
Patients with diabetic retinopathy have a high risk of developing macular edema after cataract surgery. Intravitreal injections of aflibercept might result in fewer patients developing macular edema in this patient population. Tracking growth of ultra-widefield imaging in disease management
October 01, 2017By Vanessa Caceres
Ultra-widefield imaging has become an important component of a thorough eye exam and is taking on a larger role in retina and comprehensive ophthalmology. Novel therapies could stem burden of diabetic eye disease
September 23, 2017By Cheryl Guttman Krader
A better understanding of the pathophysiologic mechanisms of diabetes has resulted in improved control of its local and systemic comorbidities. Further developments are needed, however, considering the growing number of diabetic patients and who are at risk for late-stage diabetic eye disease. 
August 06, 2017By Cheryl Guttman Krader
In complicated retinal detachment cases where the retina fails to reattach after completing the usual steps, retinectomy is a better technique than relaxing retinotomy–and the retinectomy is best done incrementally under air, said Steve Charles, MD. 
May 22, 2017By Cheryl Guttman Krader
Anti-VEGF therapy for Zone I retinopathy of prematurity (ROP) is associated with better structural and functional outcomes than laser therapy, but also a longer recurrence risk period, said Helen A. Mintz-Hittner, MD. Aflibercept rivals laser for diabetic retinopathy
May 14, 2017
Intravitreal aflibercept worked better than panretinal photocoagulation (PRP) for proliferative diabetic retinopathy (PDR) in a new head-to-head trial, according to researchers.